1. Home
  2. Labeler Index
  3. Glaxosmithkline Llc
  4. 0173-0873
  5. NDC Package Code: 0173-0873-06 Incruse Ellipta

NDC Package 0173-0873-06 Incruse Ellipta

Umeclidinium Aerosol, Powder Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0173-0873-06
Package Description:
1 TRAY in 1 CARTON / 1 INHALER in 1 TRAY / 7 AEROSOL, POWDER in 1 INHALER
Product Code:
0173-0873
Proprietary Name:
Incruse Ellipta
Non-Proprietary Name:
Umeclidinium
Substance Name:
Umeclidinium Bromide
Usage Information:
Umeclidinium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.
11-Digit NDC Billing Format:
00173087306
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1539251 - umeclidinium 62.5 MCG/INHAL Dry Powder Inhaler, 30 Blisters
  • RxCUI: 1539251 - 30 ACTUAT umeclidinium 0.0625 MG/ACTUAT Dry Powder Inhaler
  • RxCUI: 1539885 - Incruse Ellipta 62.5 MCG/INHAL Dry Powder Inhaler, 30 Blisters
  • RxCUI: 1539885 - 30 ACTUAT umeclidinium 0.0625 MG/ACTUAT Dry Powder Inhaler [Incruse]
  • RxCUI: 1539885 - Incruse Ellipta (umeclidinium 62.5 MCG) per ACTUAT Dry Powder Inhaler, 30 ACTUAT
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Glaxosmithkline Llc
    Dosage Form:
    Aerosol, Powder - A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • UMECLIDINIUM BROMIDE 62.5 ug/1
    • Pharmacologic Class(es):
  • Anticholinergic - [EPC] (Established Pharmacologic Class)
  • Cholinergic Antagonists - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    NDA205382
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    04-30-2014
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0173-0873-101 TRAY in 1 CARTON / 1 INHALER in 1 TRAY / 30 AEROSOL, POWDER in 1 INHALER

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0173-0873-06?

    The NDC Packaged Code 0173-0873-06 is assigned to a package of 1 tray in 1 carton / 1 inhaler in 1 tray / 7 aerosol, powder in 1 inhaler of Incruse Ellipta, a human prescription drug labeled by Glaxosmithkline Llc. The product's dosage form is aerosol, powder and is administered via oral form.

    Is NDC 0173-0873 included in the NDC Directory?

    Yes, Incruse Ellipta with product code 0173-0873 is active and included in the NDC Directory. The product was first marketed by Glaxosmithkline Llc on April 30, 2014 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0173-0873-06?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 0173-0873-06?

    The 11-digit format is 00173087306. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20173-0873-065-4-200173-0873-06